103 related articles for article (PubMed ID: 2894001)
1. A single point mutation responsible for c-mos polymorphism in cancer patients.
Lidereau R; Cole ST; Larsen CJ; Mathieu-Mahul D
Oncogene; 1987 May; 1(2):235-7. PubMed ID: 2894001
[TBL] [Abstract][Full Text] [Related]
2. [Genetic polymorphism and susceptibility to cancer].
Larsen CJ
Nouv Rev Fr Hematol (1978); 1988; 30(1-2):39-43. PubMed ID: 2898751
[TBL] [Abstract][Full Text] [Related]
3. c-Ha-ras-1 polymorphism in human breast carcinomas: evidence for a normal distribution of alleles.
Sheng ZM; Guerin M; Gabillot M; Spielmann M; Riou G
Oncogene Res; 1988 Feb; 2(3):245-50. PubMed ID: 2897104
[TBL] [Abstract][Full Text] [Related]
4. Absence of activating transmembrane mutations in the c-erbB-2 proto-oncogene in human breast cancer.
Lemoine NR; Staddon S; Dickson C; Barnes DM; Gullick WJ
Oncogene; 1990 Feb; 5(2):237-9. PubMed ID: 2181382
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism of the proto-oncogene ETS-1 in hematological malignancies.
Kerckaert JP; Duterque-Coquillaud M; Collyn-d'Hooghe M; Morel P; Majérus MA; Laï JL; Fenaux P; Bauters F; Debuire B; Loucheux-Lefebvre MH
Leukemia; 1990 Jan; 4(1):16-9. PubMed ID: 1967322
[TBL] [Abstract][Full Text] [Related]
6. Restriction fragment length polymorphism and activation of c-Ha-ras gene in urothelial cancer.
Ishikawa J; Maeda S; Kamidono S; Sugiyama T
Anticancer Res; 1988; 8(5A):915-24. PubMed ID: 2902823
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
Hal DG; Stoica G
Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
[TBL] [Abstract][Full Text] [Related]
8. DNA restriction fragment length polymorphisms at either end of the c-raf-1 locus at 3p25.
Graziano SL; Mark GE; Murray C; Mann DL; Ehrlich GD; Poiesz BJ; Weston A
Oncogene Res; 1988; 3(1):99-103. PubMed ID: 2905034
[TBL] [Abstract][Full Text] [Related]
9. Study of the c-Ha-ras-1 locus polymorphism in an Italian population with high incidence of gastric cancer.
Ranzani GN; Salerno-Mele P; Maltoni M; Talarico D; Della Valle G; Amadori D
Mol Biol Med; 1988 Dec; 5(3):145-53. PubMed ID: 2907601
[TBL] [Abstract][Full Text] [Related]
10. c-Ha-ras BamHI RFLP in human urothelial tumors and point mutations in hot codons.
Weismanová E; Kalúz S; Skorvaga M
Neoplasma; 1993; 40(4):223-7. PubMed ID: 7903794
[TBL] [Abstract][Full Text] [Related]
11. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
12. Presence of an allelic EcoRI restriction fragment of the c-mos locus in leukocyte and tumor cell DNAs of breast cancer patients.
Lidereau R; Mathieu-Mahul D; Theillet C; Renaud M; Mauchauffé M; Gest J; Larsen CJ
Proc Natl Acad Sci U S A; 1985 Oct; 82(20):7068-70. PubMed ID: 2996003
[TBL] [Abstract][Full Text] [Related]
13. Mutation of H-ras is infrequent in bladder cancer: confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing.
Knowles MA; Williamson M
Cancer Res; 1993 Jan; 53(1):133-9. PubMed ID: 8093230
[TBL] [Abstract][Full Text] [Related]
14. Optimization of restriction fragment length polymorphism and single strand conformation polymorphism analysis for the detection of point mutations of ras oncogenes in paraffin-embedded tissues.
Weise B; Ghebremedhin E; Zschunke F; Radzun HJ
Gen Diagn Pathol; 1996 Jun; 142(1):45-52. PubMed ID: 8793486
[TBL] [Abstract][Full Text] [Related]
15. [Polymorphism of restriction fragments of the Ha-ras-1 protooncogene in patients with carcinoma and ulcers of the stomach].
Novikov LB; Fedorov SN; Iatsuk OS; Tlevlesov NIa; Levanova GI; Kalinovskiĭ VP; Seĭts IF
Eksp Onkol; 1989; 11(5):66-70. PubMed ID: 2571493
[TBL] [Abstract][Full Text] [Related]
16. Allelic variation of the c-raf-1 proto-oncogene in human lymphoma and leukemia.
Trench GC; Southall M; Smith P; Kidson C
Oncogene; 1989 Apr; 4(4):507-10. PubMed ID: 2566145
[TBL] [Abstract][Full Text] [Related]
17. [Oncogenes and tumor suppressor genes of human breast cancer].
Takita K; Sato T; Nakamura Y
Tanpakushitsu Kakusan Koso; 1993 Feb; 38(3):305-13. PubMed ID: 8098157
[No Abstract] [Full Text] [Related]
18. A frequent restriction fragment length polymorphism in the human metallothionein-II processed gene region is evolutionarily conserved.
Varshney U; Hoar DI; Starozik D; Gedamu L
Mol Biol Med; 1984 Jun; 2(3):193-206. PubMed ID: 6100387
[TBL] [Abstract][Full Text] [Related]
19. Activated N-ras in a human rectal carcinoma cell line associated with clonal homozygosity in myb locus-restriction fragment polymorphism.
Yuasa Y; Reddy EP; Rhim JS; Tronick SR; Aaronson SA
Jpn J Cancer Res; 1986 Jul; 77(7):639-47. PubMed ID: 3017909
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the G/C polymorphism in the 5'-untranslated region of the RAD51 gene in breast cancer.
Blasiak J; Przybyłowska K; Czechowska A; Zadrozny M; Pertyński T; Rykała J; Kołacińska A; Morawiec Z; Drzewoski J
Acta Biochim Pol; 2003; 50(1):249-53. PubMed ID: 12673366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
